BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 18089340)

  • 1. Acute effects of a single dose of phosphodiesterase type 5 inhibitor (sildenafil) on systemic arterial blood pressure during exercise and 24-hour ambulatory blood pressure monitoring in heart transplant recipients.
    Guimaraes GV; d'Avila VM; Pires P; Bacal F; Stolf N; Bocchi E
    Transplant Proc; 2007 Dec; 39(10):3142-9. PubMed ID: 18089340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure.
    Lewis GD; Lachmann J; Camuso J; Lepore JJ; Shin J; Martinovic ME; Systrom DM; Bloch KD; Semigran MJ
    Circulation; 2007 Jan; 115(1):59-66. PubMed ID: 17179022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sildenafil on blood pressure and arterial wave reflection in treated hypertensive men.
    Mahmud A; Hennessy M; Feely J
    J Hum Hypertens; 2001 Oct; 15(10):707-13. PubMed ID: 11607801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase type 5 inhibition reverses impaired forearm exercise-induced vasodilatation in hypertensive patients.
    Attinà TM; Malatino LS; Maxwell SR; Padfield PL; Webb DJ
    J Hypertens; 2008 Mar; 26(3):501-7. PubMed ID: 18300861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sildenafil on cardiopulmonary responses during stress.
    Stanopoulos I; Hatzichristou D; Tryfon S; Tzortzis V; Apostolidis A; Argyropoulou P
    J Urol; 2003 Apr; 169(4):1417-21. PubMed ID: 12629375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.
    Lewis GD; Shah R; Shahzad K; Camuso JM; Pappagianopoulos PP; Hung J; Tawakol A; Gerszten RE; Systrom DM; Bloch KD; Semigran MJ
    Circulation; 2007 Oct; 116(14):1555-62. PubMed ID: 17785618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
    Botha P; Parry G; Dark JH; Macgowan GA
    J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study.
    Guazzi M; Vicenzi M; Arena R; Guazzi MD
    Circ Heart Fail; 2011 Jan; 4(1):8-17. PubMed ID: 21036891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 5'-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial.
    Behling A; Rohde LE; Colombo FC; Goldraich LA; Stein R; Clausell N
    J Card Fail; 2008 Apr; 14(3):189-97. PubMed ID: 18381181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sildenafil citrate upon myocardial ischemia in patients with chronic stable angina in therapy with beta-blockers.
    Patrizi R; Leonardo F; Pelliccia F; Chierchia SL; Galetta P; Cerquetani E; Frascà F; Fini M; Rosano GM
    Ital Heart J; 2001 Nov; 2(11):841-4. PubMed ID: 11770869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute phosphodiesterase 5 inhibition mimics hemodynamic effects of B-type natriuretic peptide and potentiates B-type natriuretic peptide effects in failing but not normal canine heart.
    Forfia PR; Lee M; Tunin RS; Mahmud M; Champion HC; Kass DA
    J Am Coll Cardiol; 2007 Mar; 49(10):1079-88. PubMed ID: 17349888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship.
    Garg N; Sharma MK; Sinha N
    Int J Cardiol; 2007 Sep; 120(3):306-13. PubMed ID: 17174417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist.
    Webb DJ; Freestone S; Allen MJ; Muirhead GJ
    Am J Cardiol; 1999 Mar; 83(5A):21C-28C. PubMed ID: 10078539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effects of sildenafil on flow mediated dilatation and cardiovascular autonomic nerve function in type 2 diabetic patients.
    Stirban A; Laude D; Elghozi JL; Sander D; Agelink MW; Hilz MJ; Ziegler D
    Diabetes Metab Res Rev; 2009 Feb; 25(2):136-43. PubMed ID: 19116943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: a double-blind, placebo-controlled, randomized, crossover trial.
    Parker JD; Bart BA; Webb DJ; Koren MJ; Siegel RL; Wang H; Malhotra B; Jen F; Glue P
    Crit Care Med; 2007 Aug; 35(8):1863-8. PubMed ID: 17522570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effects of enalapril on basal arterial pressure at rest and during exercise and on cardiac performance in hypertensive athletes].
    D'Este D; Giada F; Sartori F; Noventa D; Cinquemani S; Mantovan R; Pascotto P
    G Ital Cardiol; 1990 Oct; 20(10):935-9. PubMed ID: 2090533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term use of sildenafil in the therapeutic management of heart failure.
    Guazzi M; Samaja M; Arena R; Vicenzi M; Guazzi MD
    J Am Coll Cardiol; 2007 Nov; 50(22):2136-44. PubMed ID: 18036451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure.
    Guazzi M; Tumminello G; Di Marco F; Fiorentini C; Guazzi MD
    J Am Coll Cardiol; 2004 Dec; 44(12):2339-48. PubMed ID: 15607396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of exercise training on 24-hour ambulatory blood pressure monitoring in heart failure patients.
    Carvalho VO; Ciolac EG; Guimarães GV; Bocchi EA
    Congest Heart Fail; 2009; 15(4):176-80. PubMed ID: 19627291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to exercise and ambulatory blood pressure monitoring in essential hypertension.
    Khanna CM; Dubey YS; Khanna G; Kaur G
    J Assoc Physicians India; 1999 Apr; 47(4):393-6. PubMed ID: 10778522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.